enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. What Are GLP-1 Medications & Who Should Use Them? Here ... - AOL

   www.aol.com/glp-1-medications-them-heres...

   GLP-1 agonists are a class of medications that mimic the action of the hormone GLP-1 (glucagon-like peptide-1), which is involved in insulin production and appetite regulation. “GLP-1 stands for ...

3. GLP-1 receptor agonist - Wikipedia

   en.wikipedia.org/wiki/GLP-1_receptor_agonist

   Glucagon-like peptide-1 (GLP-1) receptor agonists, also known as GLP-1 analogs, GLP-1DAs, or incretin mimetics, [1] are a class of anorectic drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor. They mimic the actions of the endogenous incretin hormone GLP-1, which is released by the gut after eating.

4. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   Originally available only by prescription, it was approved by the FDA for over-the-counter sale in February 2007. [32] In May 2010, the U.S. Food and Drug Administration (FDA) approved a revised label for Xenical to include new safety information about rare cases of severe liver injury that have been reported with the use of this medication. [33]

5. How Effective Are GLP-1s Like Wegovy & Ozempic for ... - AOL

   www.aol.com/effective-glp-1s-wegovy-ozempic...

   List of GLP-1 Agonists. Some GLP-1s were approved for obesity 10-20 years ago, but many of us are just hearing about them now. Currently, the only FDA-approved GLP-1 medications for weight loss ...

6. Dulaglutide - Wikipedia

   en.wikipedia.org/wiki/Dulaglutide

   It is a glucagon-like peptide-1 receptor agonist (GLP-1 agonist) consisting of GLP-1(7-37) covalently linked to an Fc fragment of human IgG4. GLP-1 is a hormone that is involved in normalizing the level of glucose in blood (glycemia). The Food and Drug Administration (FDA) approved dulaglutide for use in the United States in September 2014.

7. Weight Loss Injections: What You Need to Know, From ... - AOL

   www.aol.com/lifestyle/weight-loss-injections...

   Together, the GLP-1 and GIP receptor agonists can produce a reduced appetite that leads to reduced food intake — according to an Eli Lilly-sponsored study. And at the risk of stating the obvious ...